YIF1A
gene geneOn this page
Also known as YIF1P54TMFinGER7
Summary
YIF1A (Yip1 interacting factor homolog A, membrane trafficking protein, HGNC:16688) is a protein-coding gene on chromosome 11q13.2, encoding Protein YIF1A (O95070). Possible role in transport between endoplasmic reticulum and Golgi.
Predicted to be involved in endoplasmic reticulum to Golgi vesicle-mediated transport. Located in Golgi apparatus and endoplasmic reticulum-Golgi intermediate compartment.
Source: NCBI Gene 10897 — RefSeq curated summary.
At a glance
- GWAS associations: 3
- Clinical variants (ClinVar): 72 total
- Druggable target: yes
- MANE Select transcript:
NM_020470
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:16688 |
| Approved symbol | YIF1A |
| Name | Yip1 interacting factor homolog A, membrane trafficking protein |
| Location | 11q13.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | YIF1P, 54TM, FinGER7 |
| Ensembl gene | ENSG00000174851 |
| Ensembl biotype | protein_coding |
| OMIM | 611484 |
| Entrez | 10897 |
Gene structure
Transcript identifiers
Ensembl transcripts: 14 — 7 protein_coding, 5 retained_intron, 1 nonsense_mediated_decay, 1 protein_coding_CDS_not_defined
ENST00000359461, ENST00000376899, ENST00000376901, ENST00000431556, ENST00000471387, ENST00000474986, ENST00000484814, ENST00000485820, ENST00000494836, ENST00000496746, ENST00000526497, ENST00000528575, ENST00000534374, ENST00000715691
RefSeq mRNA: 2 — MANE Select: NM_020470
NM_001300861, NM_020470
CCDS: CCDS73325, CCDS8132
Canonical transcript exons
ENST00000376901 — 8 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003508439 | 66287812 | 66287916 |
| ENSE00003547691 | 66288081 | 66288292 |
| ENSE00003636201 | 66284873 | 66284966 |
| ENSE00003679340 | 66285701 | 66285758 |
| ENSE00003686935 | 66285381 | 66285536 |
| ENSE00003689946 | 66287598 | 66287676 |
| ENSE00004027607 | 66284580 | 66284783 |
| ENSE00004027608 | 66288955 | 66289143 |
Expression profiles
Bgee: expression breadth ubiquitous, 253 present calls, max score 98.00.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 66.3525 / max 286.7559, expressed in 1818 samples.
FANTOM5 promoters (7 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 120769 | 39.9199 | 1813 |
| 120768 | 10.9653 | 1669 |
| 120766 | 8.0443 | 1600 |
| 120767 | 6.5161 | 1602 |
| 120765 | 0.5645 | 326 |
| 120764 | 0.2079 | 80 |
| 120763 | 0.1346 | 47 |
Top tissues by expression
280 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| stromal cell of endometrium | CL:0002255 | 98.00 | gold quality |
| adenohypophysis | UBERON:0002196 | 97.61 | gold quality |
| right lobe of liver | UBERON:0001114 | 97.29 | gold quality |
| body of pancreas | UBERON:0001150 | 96.94 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 96.55 | gold quality |
| pituitary gland | UBERON:0000007 | 96.35 | gold quality |
| left uterine tube | UBERON:0001303 | 96.29 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 96.21 | gold quality |
| ascending aorta | UBERON:0001496 | 96.18 | gold quality |
| thoracic aorta | UBERON:0001515 | 96.14 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 95.98 | gold quality |
| islet of Langerhans | UBERON:0000006 | 95.96 | gold quality |
| body of stomach | UBERON:0001161 | 95.92 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 95.90 | gold quality |
| left coronary artery | UBERON:0001626 | 95.83 | gold quality |
| right ovary | UBERON:0002118 | 95.76 | gold quality |
| apex of heart | UBERON:0002098 | 95.70 | gold quality |
| gastrocnemius | UBERON:0001388 | 95.54 | gold quality |
| right coronary artery | UBERON:0001625 | 95.50 | gold quality |
| mucosa of stomach | UBERON:0001199 | 95.48 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 95.44 | gold quality |
| lower esophagus | UBERON:0013473 | 95.42 | gold quality |
| right adrenal gland | UBERON:0001233 | 95.37 | gold quality |
| tibial nerve | UBERON:0001323 | 95.37 | gold quality |
| pancreas | UBERON:0001264 | 95.36 | gold quality |
| body of uterus | UBERON:0009853 | 95.33 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 95.29 | gold quality |
| transverse colon | UBERON:0001157 | 95.15 | gold quality |
| left adrenal gland | UBERON:0001234 | 95.14 | gold quality |
| aorta | UBERON:0000947 | 95.12 | gold quality |
Single-cell (SCXA)
Detected in 6 experiment(s), a significant marker in 4.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-HCAD-5 | yes | 39.44 |
| E-HCAD-13 | yes | 26.37 |
| E-ANND-3 | yes | 15.80 |
| E-CURD-112 | yes | 14.72 |
| E-MTAB-7606 | no | 371.33 |
| E-MTAB-7052 | no | 206.20 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 2)
- Human Yip1A (YIPF5) interacts with and localizes human Yif1 (YIF1A) to the Golgi apparatus. (PMID:15990086)
- YIF1A is involved in the maintenance of the Golgi structure. (PMID:18718466)
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | yif1a | ENSDARG00000019636 |
| mus_musculus | Yif1a | ENSMUSG00000024875 |
| rattus_norvegicus | Yif1a | ENSRNOG00000020201 |
| drosophila_melanogaster | Yif1 | FBGN0288631 |
| caenorhabditis_elegans | WBGENE00010178 |
Paralogs (1): YIF1B (ENSG00000167645)
Protein
Protein identifiers
Protein YIF1A — O95070 (reviewed: O95070)
Alternative names: 54TMp, YIP1-interacting factor homolog A
All UniProt accessions (7): O95070, A6NGW1, C9JST7, E9PIZ0, E9PK42, E9PP02, E9PS11
UniProt curated annotations — full annotation on UniProt →
Function. Possible role in transport between endoplasmic reticulum and Golgi.
Subunit / interactions. Interacts with YIPF5.
Subcellular location. Endoplasmic reticulum membrane. Golgi apparatus membrane. Endoplasmic reticulum-Golgi intermediate compartment membrane.
Similarity. Belongs to the YIF1 family.
RefSeq proteins (2): NP_001287790, NP_065203* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR005578 | Yif1_fam | Family |
Pfam: PF03878
UniProt features (16 total): topological domain 5, transmembrane region 5, modified residue 2, initiator methionine 1, chain 1, region of interest 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-O95070-F1 | 74.14 | 0.34 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (2): 2, 12
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-381038 | XBP1(S) activates chaperone genes |
MSigDB gene sets: 144 (showing top):
REACTOME_UNFOLDED_PROTEIN_RESPONSE_UPR, GOBP_VESICLE_MEDIATED_TRANSPORT, chr11q13, AP1_Q4_01, GOBP_ENDOPLASMIC_RETICULUM_TO_GOLGI_VESICLE_MEDIATED_TRANSPORT, GOCC_COATED_VESICLE, TGANTCA_AP1_C, NRF2_Q4, RYTTCCTG_ETS2_B, NIKOLSKY_BREAST_CANCER_11Q12_Q14_AMPLICON, DANG_BOUND_BY_MYC, NFE2_01, GOCC_NUCLEAR_OUTER_MEMBRANE_ENDOPLASMIC_RETICULUM_MEMBRANE_NETWORK, GOCC_ENDOPLASMIC_RETICULUM_GOLGI_INTERMEDIATE_COMPARTMENT_MEMBRANE, GOCC_ENDOPLASMIC_RETICULUM_GOLGI_INTERMEDIATE_COMPARTMENT
GO Biological Process (3): endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888), protein transport (GO:0015031), vesicle-mediated transport (GO:0016192)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (8): Golgi membrane (GO:0000139), endoplasmic reticulum membrane (GO:0005789), endoplasmic reticulum-Golgi intermediate compartment (GO:0005793), Golgi apparatus (GO:0005794), COPII-coated ER to Golgi transport vesicle (GO:0030134), endoplasmic reticulum-Golgi intermediate compartment membrane (GO:0033116), endoplasmic reticulum (GO:0005783), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| IRE1alpha activates chaperones | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cytoplasm | 4 |
| intracellular membrane-bounded organelle | 3 |
| transport | 2 |
| bounding membrane of organelle | 2 |
| endomembrane system | 2 |
| intercellular transport | 1 |
| intracellular transport | 1 |
| Golgi vesicle transport | 1 |
| intracellular protein localization | 1 |
| establishment of protein localization | 1 |
| cellular process | 1 |
| binding | 1 |
| Golgi apparatus | 1 |
| organelle membrane | 1 |
| nuclear outer membrane-endoplasmic reticulum membrane network | 1 |
| endoplasmic reticulum subcompartment | 1 |
| coated vesicle | 1 |
| endoplasmic reticulum-Golgi intermediate compartment | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
1082 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| YIF1A | YIPF5 | Q969M3 | 986 |
| YIF1A | RAB1A | P11476 | 719 |
| YIF1A | GOLPH3 | Q9H4A6 | 680 |
| YIF1A | YIPF4 | Q9BSR8 | 675 |
| YIF1A | VTI1B | Q9UEU0 | 655 |
| YIF1A | YIPF3 | Q9GZM5 | 645 |
| YIF1A | VAPB | O95292 | 643 |
| YIF1A | YIPF6 | Q96EC8 | 635 |
| YIF1A | SNX1 | Q13596 | 580 |
| YIF1A | YIPF7 | Q8N8F6 | 560 |
| YIF1A | STX5 | Q13190 | 550 |
| YIF1A | PREB | Q9HCU5 | 549 |
| YIF1A | RABAC1 | Q9UI14 | 548 |
| YIF1A | YIPF2 | Q9BWQ6 | 545 |
| YIF1A | GOLGA2 | Q08379 | 483 |
IntAct
327 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| YIF1A | YIPF5 | psi-mi:“MI:0915”(physical association) | 0.790 |
| YIF1A | TMEM17 | psi-mi:“MI:0915”(physical association) | 0.660 |
| TMEM9B | DNAJC13 | psi-mi:“MI:0914”(association) | 0.640 |
| YIF1A | GJA8 | psi-mi:“MI:0915”(physical association) | 0.560 |
| YIF1A | FAM210B | psi-mi:“MI:0915”(physical association) | 0.560 |
| YIF1A | AQP6 | psi-mi:“MI:0915”(physical association) | 0.560 |
| YIF1A | SCN4B | psi-mi:“MI:0915”(physical association) | 0.560 |
| YIF1A | GPR42 | psi-mi:“MI:0915”(physical association) | 0.560 |
| YIF1A | TMEM248 | psi-mi:“MI:0915”(physical association) | 0.560 |
| YIF1A | TMX2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| YIF1A | SCN3B | psi-mi:“MI:0915”(physical association) | 0.560 |
| YIF1A | PTGES | psi-mi:“MI:0915”(physical association) | 0.560 |
| YIF1A | FFAR2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| YIF1A | REEP2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| YIF1A | MSMO1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| YIF1A | SEC23IP | psi-mi:“MI:0915”(physical association) | 0.560 |
| YIF1A | SNX10 | psi-mi:“MI:0915”(physical association) | 0.560 |
| YIF1A | MYG1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| YIF1A | NDRG4 | psi-mi:“MI:0915”(physical association) | 0.560 |
BioGRID (168): YIF1A (Two-hybrid), YIF1A (Affinity Capture-MS), YIF1A (Affinity Capture-MS), YIF1A (Affinity Capture-MS), YIF1A (Affinity Capture-MS), YIF1A (Affinity Capture-MS), YIF1A (Proximity Label-MS), YIF1A (Proximity Label-MS), YIF1A (Affinity Capture-MS), YIF1A (Affinity Capture-MS), YIF1A (Affinity Capture-MS), YIF1A (Affinity Capture-MS), YIF1A (Affinity Capture-MS), YIF1A (Affinity Capture-MS), YIF1A (Affinity Capture-MS)
ESM2 similar proteins: A2YMP7, A4RE85, B2WCU2, B3M9W1, B3NDM7, B4GRI8, B4HIJ8, B4J043, B4L0H1, B4LIH0, B4MXW6, B4PD01, B4QLP9, O14828, O35609, O95070, P87148, Q0JAI9, Q0UUE1, Q1E5A9, Q29BL9, Q3T196, Q4FZQ0, Q58DR5, Q5APC0, Q5BJH7, Q5RBL0, Q5U3G6, Q60EA5, Q6GN58, Q6P301, Q6P6G5, Q6PC24, Q6Z8F5, Q75IC7, Q7F613, Q7SDN3, Q8H5X5, Q8MRQ4, Q91VU1
Diamond homologs: O95070, P53845, P87148, Q3T196, Q4FZQ0, Q5BJH7, Q5U3G6, Q6GN58, Q6P301, Q6PC24, Q6PEC3, Q91XB7, Q9CX30
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
72 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 58 |
| Likely benign | 3 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1544 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 11:66284867:ACTC:A | donor_loss | 1.0000 |
| 11:66284869:T:TA | donor_loss | 1.0000 |
| 11:66284871:A:AC | donor_gain | 1.0000 |
| 11:66284872:C:CC | donor_gain | 1.0000 |
| 11:66284872:CA:C | donor_gain | 1.0000 |
| 11:66284872:CAA:C | donor_gain | 1.0000 |
| 11:66284872:CAAT:C | donor_gain | 1.0000 |
| 11:66284872:CAATG:C | donor_gain | 1.0000 |
| 11:66284962:TCATT:T | acceptor_gain | 1.0000 |
| 11:66284963:CATT:C | acceptor_gain | 1.0000 |
| 11:66284963:CATTC:C | acceptor_gain | 1.0000 |
| 11:66284964:ATT:A | acceptor_gain | 1.0000 |
| 11:66284965:TT:T | acceptor_gain | 1.0000 |
| 11:66284967:C:CC | acceptor_gain | 1.0000 |
| 11:66284967:CTGG:C | acceptor_loss | 1.0000 |
| 11:66284973:G:C | acceptor_gain | 1.0000 |
| 11:66284973:G:GC | acceptor_gain | 1.0000 |
| 11:66285375:GCTCA:G | donor_loss | 1.0000 |
| 11:66285376:CTCA:C | donor_loss | 1.0000 |
| 11:66285377:TCA:T | donor_loss | 1.0000 |
| 11:66285378:CACCC:C | donor_loss | 1.0000 |
| 11:66285379:A:AC | donor_gain | 1.0000 |
| 11:66285379:AC:A | donor_gain | 1.0000 |
| 11:66285379:ACC:A | donor_gain | 1.0000 |
| 11:66285380:C:CA | donor_loss | 1.0000 |
| 11:66285380:C:CC | donor_gain | 1.0000 |
| 11:66285380:CC:C | donor_gain | 1.0000 |
| 11:66285380:CCC:C | donor_gain | 1.0000 |
| 11:66285380:CCCCA:C | donor_gain | 1.0000 |
| 11:66285388:A:AC | donor_gain | 1.0000 |
AlphaMissense
1882 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 11:66285533:G:C | F163L | 1.000 |
| 11:66285533:G:T | F163L | 1.000 |
| 11:66285535:A:G | F163L | 1.000 |
| 11:66285503:G:C | S173R | 0.999 |
| 11:66285503:G:T | S173R | 0.999 |
| 11:66285505:T:G | S173R | 0.999 |
| 11:66285534:A:C | F163C | 0.999 |
| 11:66285534:A:G | F163S | 0.999 |
| 11:66285753:C:G | A145P | 0.999 |
| 11:66287600:G:T | P142H | 0.999 |
| 11:66287603:A:T | I141N | 0.999 |
| 11:66287671:C:A | W118C | 0.999 |
| 11:66287671:C:G | W118C | 0.999 |
| 11:66288136:G:T | A63D | 0.999 |
| 11:66284677:G:C | P281R | 0.998 |
| 11:66284902:A:G | W236R | 0.998 |
| 11:66284902:A:T | W236R | 0.998 |
| 11:66285714:C:G | G158R | 0.998 |
| 11:66285725:C:T | G154E | 0.998 |
| 11:66285726:C:G | G154R | 0.998 |
| 11:66285726:C:T | G154R | 0.998 |
| 11:66285734:A:T | L151H | 0.998 |
| 11:66287600:G:C | P142R | 0.998 |
| 11:66287603:A:C | I141S | 0.998 |
| 11:66287609:A:G | L139P | 0.998 |
| 11:66287825:G:T | P112H | 0.998 |
| 11:66287843:A:G | L106P | 0.998 |
| 11:66287845:C:A | K105N | 0.998 |
| 11:66287845:C:G | K105N | 0.998 |
| 11:66287867:T:A | D98V | 0.998 |
dbSNP variants (sampled 300 via entrez): RS1000183080 (11:66286718 C>T), RS1002223555 (11:66288508 A>C), RS1002884122 (11:66288695 C>T), RS1003461071 (11:66285182 C>T), RS1004554132 (11:66285097 A>G), RS1004625574 (11:66286546 G>A), RS1004882011 (11:66290675 T>G), RS1005017782 (11:66291005 C>T), RS1006169265 (11:66286219 G>A), RS1006251445 (11:66287715 G>A,C), RS1006367490 (11:66287123 T>C), RS1007020164 (11:66288392 G>A), RS1007131018 (11:66286055 G>A), RS1007354037 (11:66287052 C>T), RS1007972282 (11:66289226 T>C)
Disease associations
OMIM: gene MIM:611484 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
3 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST001241_12 | Bipolar disorder | 2.000000e-07 |
| GCST002726_39 | Glucose homeostasis traits | 4.000000e-06 |
| GCST008103_21 | Bipolar disorder | 2.000000e-08 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0006831 | acute insulin response measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: yes
ChEMBL targets (1): CHEMBL5465281 (SINGLE PROTEIN)
PharmGKB: 1 entry (VIP=true, CPIC=false)
ChEMBL bioactivities
2 potent at pChembl≥5 of 2 total, top 2 by pChembl (potency: 10 = 0.1 nM, 6 = 1 µM).
| pChembl | Type | Value | Unit | Molecule |
|---|---|---|---|---|
| 7.52 | Kd | 30.01 | nM | CHEMBL3752910 |
| 7.52 | ED50 | 30.01 | nM | CHEMBL3752910 |
PubChem BioAssay actives
1 with measured affinity, of 3 total; 1 most potent distinct compounds. Largely complementary to BindingDB; screening values are coarse (µM, 4 dp), so sub-nM hits tie at the floor.
| Compound | Assay | Type | Value | Unit |
|---|---|---|---|---|
| 4-methyl-3-[(1-methyl-6-pyridin-3-ylpyrazolo[3,4-d]pyrimidin-4-yl)amino]-N-[3-(trifluoromethyl)phenyl]benzamide | 2149966: Binding affinity to human YIF1A incubated for 45 mins by Kinobead based pull down assay | kd | 0.0300 | uM |
CTD chemical–gene interactions
29 total (human), top 29 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | increases expression, increases methylation | 3 |
| aristolochic acid I | decreases expression | 1 |
| GSK-J4 | decreases expression | 1 |
| sodium arsenite | increases abundance, increases expression, affects cotreatment | 1 |
| cobaltous chloride | decreases expression | 1 |
| manganese chloride | increases abundance, increases expression, affects cotreatment | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| perfluorooctane sulfonic acid | increases expression | 1 |
| ICG 001 | increases expression | 1 |
| abrine | increases expression | 1 |
| jinfukang | affects cotreatment, increases expression | 1 |
| Temozolomide | decreases expression | 1 |
| Air Pollutants | decreases expression, increases abundance | 1 |
| Arsenic | affects cotreatment, increases abundance, increases expression | 1 |
| Atrazine | increases expression | 1 |
| Cisplatin | affects cotreatment, increases expression | 1 |
| Cytarabine | decreases expression | 1 |
| Diazinon | increases methylation | 1 |
| Doxorubicin | decreases expression | 1 |
| Fluorouracil | affects response to substance | 1 |
| Manganese | affects cotreatment, increases abundance, increases expression | 1 |
| Smoke | decreases expression | 1 |
| Thiram | decreases expression | 1 |
| Urethane | decreases expression | 1 |
| Cyclosporine | decreases expression | 1 |
| Thapsigargin | increases expression | 1 |
| Copper Sulfate | decreases expression | 1 |
| Acrylamide | decreases expression | 1 |
| Particulate Matter | decreases expression, increases abundance | 1 |
ChEMBL screening assays
2 unique, capped per target: 2 binding
Representative assays (with source publication via chembl_document):
| Assay ID | Type | Description | Source paper |
|---|---|---|---|
| CHEMBL5338433 | Binding | Binding affinity to Yif1a (unknown origin) at 200 uM preincubated for 2 hrs followed by pronase addition and measured after 30 mins by coomassie blue staining based SDS-PAGE gel analysis | Structurally Diverse Alkaloids with Anti-Renal-Fibrosis Activity from the Centipede Scolopendra subspinipes mutilans. — J Nat Prod |
Cellosaurus cell lines
1 cell lines: 1 transformed cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_B3LH | Abcam HEK293T YIF1A KO | Transformed cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.